US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Rezolute, Inc.

5.09

+0.43009.23%

Post-market: 5.160.0699+1.37%19:57 EDT

Volume:6.50M

Turnover:33.28M

Market Cap:490.13M

PE:-6.33

High:5.64

Open:4.68

Low:4.65

Close:4.66

52wk High:11.46

52wk Low:1.07

Shares:96.29M

Float Shares:72.51M

Volume Ratio:7.56

T/O Rate:8.97%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.8039

EPS(LYR):-0.9791

ROE:-81.73%

ROA:-48.74%

PB:4.20

PE(LYR):-5.20

Loading ...

Overview Company News Filings

Rezolute reports Phase 3 sunRIZE CGM data showing improved hypoglycemia control with ersodetug

Rezolute Announces Oral Presentation of Results From Its Phase 3 Sunrize Study of Ersodetug in Patients With Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting

THOMSON REUTERS

Rezolute to present Phase 3 sunRIZE ersodetug data in congenital hyperinsulinism at PES meeting

Rezolute publishes corporate presentation on ersodetug Phase 3 hyperinsulinism programs

Rezolute CFO Daron Evans reports purchase of common shares worth $28,500

Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT), Atara Biotherapeutics (ATRA) and Rezolute (RZLT)

Rezolute Raised to Outperform From Neutral by Wedbush

Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (SRPT), Rezolute (RZLT) and Demant (OtherWILLF)

Rezolute upgraded to Outperform from Neutral at Wedbush

H.C. Wainwright Sticks to Their Buy Rating for Rezolute (RZLT)

Wedbush Upgrades Rezolute to Outperform From Neutral, Raises Price Target to $5 From $2

MT Newswires Live

Analysts Are Bullish on Top Healthcare Stocks: NRX Pharmaceuticals (NRXP), Rezolute (RZLT)

BUZZ-Rezolute rises after FDA talks on rare low blood sugar disease drug

Rezolute Says It Had Encouraging FDA Meeting on Congenital Hyperinsulinism Drug Despite Missed Endpoint

Rezolute reports FDA meeting outcomes for its Phase 3 sunRIZE trial of ersodetug in congenital hyperinsulinism

Rezolute Provides Update on Its Congenital Hyperinsulinism Program Following FDA Meeting

THOMSON REUTERS

Rezolute Inc - Expects Program Update in Second Half of 2026

THOMSON REUTERS

Rezolute Inc: FDA Encouraged Company to Submit Study Reports and Analysis Datasets for Agency's Independent Evaluation

THOMSON REUTERS

Rezolute Inc - FDA Acknowledges Challenges of Behavioral Factors and Smbg Limitations in Congenital Hi Trials

THOMSON REUTERS

XOMA Royalty FY 2025 revenue rose 83% to USD 52.15 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/RZLT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RZLT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RZLT\",,,,,undefined,":{"symbol":"RZLT","market":"US","secType":"STK","nameCN":"Rezolute, Inc.","latestPrice":5.09,"timestamp":1787342400000,"preClose":4.66,"halted":0,"volume":6500573,"hourTrading":{"tag":"盘后","latestPrice":5.1599,"preClose":5.09,"latestTime":"19:57 EDT","volume":5506,"amount":28021.5819,"timestamp":1787356651756,"change":0.0699,"changeRate":0.013733,"amplitude":0.025226},"delay":0,"changeRate":0.09227467811158792,"floatShares":72507800,"shares":96292331,"eps":-0.803925,"marketStatus":"Market Closed","change":0.43,"latestTime":"08-21 16:00:00 EDT","open":4.68,"high":5.635,"low":4.646,"amount":33277802.8577311,"amplitude":0.212232,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.803925,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":4.66,"preHourTrading":{"tag":"盘前","latestPrice":4.69,"preClose":4.66,"latestTime":"09:29 EDT","volume":5444,"amount":25990.4878432,"timestamp":1787318999999,"change":0.03,"changeRate":0.006438,"amplitude":0.021094},"postHourTrading":{"tag":"盘后","latestPrice":5.1599,"preClose":5.09,"latestTime":"19:57 EDT","volume":5506,"amount":28021.5819,"timestamp":1787356651756,"change":0.0699,"changeRate":0.013733,"amplitude":0.025226},"volumeRatio":7.564322491938306,"impliedVol":0.5725,"impliedVolPercentile":0.0438},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RZLT\",,,,,undefined,":{"symbol":"RZLT","floatShares":72507800,"roa":"-48.74%","roe":"-81.73%","lyrEps":-0.979114,"volumeRatio":7.564322491938306,"shares":96292331,"dividePrice":0,"high":5.635,"amplitude":0.212232,"preClose":4.66,"low":4.646,"week52Low":1.07,"pbRate":"4.20","week52High":11.4565,"institutionHeld":0,"latestPrice":5.09,"eps":-0.803925,"divideRate":0,"volume":6500573,"delay":0,"ttmEps":-0.803925,"open":4.68,"prevYearClose":2.36,"prevWeekClose":4.6,"prevMonthClose":4.72,"prevQuarterClose":5.2,"fiveDayClose":4.6,"twentyDayClose":4.99,"sixtyDayClose":3.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RZLT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-12","symbol":"RZLT","fiscalQuarterEnding":"2026/03","expectedEps":-0.13,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.16},{"market":"US","date":"2026-02-12","symbol":"RZLT","fiscalQuarterEnding":"2025/12","expectedEps":-0.16,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1770872400000,"reportTimeType":"post","actualEps":-0.22},{"market":"US","date":"2025-11-06","symbol":"RZLT","fiscalQuarterEnding":"2025/09","expectedEps":-0.27,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2025-09-17","symbol":"RZLT","fiscalQuarterEnding":"2025/06","expectedEps":-0.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1758081600000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2025-05-13","symbol":"RZLT","fiscalQuarterEnding":"2025/03","expectedEps":-0.22,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RZLT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RZLT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.4,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":10,"updateTime":1780459200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RZLT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RZLT","date":"2026-08-21","current":-6.331436,"percent":0.118561,"low":-13.143128,"twenty":-4.659764,"median":-2.849762,"eighty":-1.563431,"high":-0.489687,"avg":-3.455911,"sd":2.466962,"marketCap":486815143},"quantilePoints":[{"date":"2021-08-27","current":-4.337286,"twenty":-4.577488,"median":-2.194663,"eighty":-0.909452,"marketCap":77893311},{"date":"2021-09-03","current":-4.363922,"twenty":-4.577488,"median":-2.194663,"eighty":-0.909452,"marketCap":78371684},{"date":"2021-09-10","current":-5.05346,"twenty":-4.600065,"median":-2.194663,"eighty":-0.909452,"marketCap":90755088},{"date":"2021-09-17","current":-3.340513,"twenty":-4.610419,"median":-2.194663,"eighty":-0.909452,"marketCap":69823393},{"date":"2021-09-24","current":-3.319892,"twenty":-4.610419,"median":-2.194663,"eighty":-0.909452,"marketCap":69392384},{"date":"2021-10-01","current":-3.134308,"twenty":-4.610419,"median":-2.194663,"eighty":-0.909452,"marketCap":65513307},{"date":"2021-10-08","current":-3.060074,"twenty":-4.59555,"median":-2.207301,"eighty":-0.909969,"marketCap":63961676},{"date":"2021-10-15","current":-4.905974,"twenty":-4.59555,"median":-2.207301,"eighty":-0.909969,"marketCap":102544662},{"date":"2021-10-22","current":-4.795313,"twenty":-4.609293,"median":-2.207301,"eighty":-0.909969,"marketCap":100231625},{"date":"2021-10-29","current":-4.721539,"twenty":-4.610419,"median":-2.207301,"eighty":-0.909969,"marketCap":98689600},{"date":"2021-11-05","current":-4.80269,"twenty":-4.620445,"median":-2.230437,"eighty":-0.910487,"marketCap":100385827},{"date":"2021-11-12","current":-3.872664,"twenty":-4.653689,"median":-2.230437,"eighty":-0.910487,"marketCap":97273575},{"date":"2021-11-19","current":-3.56531,"twenty":-4.653689,"median":-2.230437,"eighty":-0.910487,"marketCap":89553450},{"date":"2021-11-26","current":-3.294838,"twenty":-4.653689,"median":-2.230437,"eighty":-0.910487,"marketCap":82759740},{"date":"2021-12-03","current":-2.587923,"twenty":-4.653689,"median":-2.230437,"eighty":-0.910487,"marketCap":65003452},{"date":"2021-12-10","current":-3.091984,"twenty":-4.653689,"median":-2.230437,"eighty":-0.910487,"marketCap":77664457},{"date":"2021-12-17","current":-2.729306,"twenty":-4.653689,"median":-2.230437,"eighty":-0.910487,"marketCap":68554710},{"date":"2021-12-23","current":-2.864542,"twenty":-4.653689,"median":-2.230437,"eighty":-0.910487,"marketCap":71951565},{"date":"2021-12-31","current":-2.938307,"twenty":-4.653689,"median":-2.230437,"eighty":-0.910487,"marketCap":73804395},{"date":"2022-01-07","current":-2.78463,"twenty":-4.652834,"median":-2.253573,"eighty":-0.911004,"marketCap":69944332},{"date":"2022-01-14","current":-2.766189,"twenty":-4.652834,"median":-2.253573,"eighty":-0.911004,"marketCap":69481125},{"date":"2022-01-21","current":-2.717012,"twenty":-4.652834,"median":-2.253573,"eighty":-0.911004,"marketCap":68245905},{"date":"2022-01-28","current":-2.409658,"twenty":-4.652834,"median":-2.253573,"eighty":-0.911004,"marketCap":60525780},{"date":"2022-02-04","current":-2.710865,"twenty":-4.65198,"median":-2.253573,"eighty":-0.911522,"marketCap":68091502},{"date":"2022-02-11","current":-2.444203,"twenty":-4.65198,"median":-2.253573,"eighty":-0.911522,"marketCap":74826841},{"date":"2022-02-18","current":-2.139313,"twenty":-4.65198,"median":-2.196174,"eighty":-0.911522,"marketCap":65492932},{"date":"2022-02-25","current":-1.219561,"twenty":-4.65198,"median":-2.170419,"eighty":-0.911522,"marketCap":37335638},{"date":"2022-03-04","current":-1.346599,"twenty":-4.65198,"median":-2.089173,"eighty":-0.911522,"marketCap":41224767},{"date":"2022-03-11","current":-1.270376,"twenty":-4.65198,"median":-2.089173,"eighty":-0.911522,"marketCap":38891290},{"date":"2022-03-18","current":-2.083417,"twenty":-4.65198,"median":-2.016306,"eighty":-0.911522,"marketCap":63781715},{"date":"2022-03-25","current":-1.971624,"twenty":-4.65198,"median":-2.003886,"eighty":-0.911522,"marketCap":60359282},{"date":"2022-04-01","current":-1.839504,"twenty":-4.65198,"median":-1.945404,"eighty":-0.911522,"marketCap":56314587},{"date":"2022-04-08","current":-1.92589,"twenty":-4.65198,"median":-1.900874,"eighty":-0.911522,"marketCap":58959195},{"date":"2022-04-14","current":-1.7582,"twenty":-4.65198,"median":-1.880156,"eighty":-0.911522,"marketCap":53825545},{"date":"2022-04-22","current":-1.676896,"twenty":-4.65198,"median":-1.866934,"eighty":-0.911522,"marketCap":51336502},{"date":"2022-04-29","current":-1.930971,"twenty":-4.65198,"median":-1.855896,"eighty":-0.911522,"marketCap":59114760},{"date":"2022-05-06","current":-4.223359,"twenty":-4.65198,"median":-1.855896,"eighty":-0.911522,"marketCap":129293899},{"date":"2022-05-13","current":-3.038811,"twenty":-4.651125,"median":-1.855896,"eighty":-0.911522,"marketCap":115860766},{"date":"2022-05-20","current":-2.721718,"twenty":-4.651125,"median":-1.855896,"eighty":-0.911522,"marketCap":103770947},{"date":"2022-05-27","current":-2.721718,"twenty":-4.651125,"median":-1.855896,"eighty":-0.911522,"marketCap":103770947},{"date":"2022-06-03","current":-2.483898,"twenty":-4.651125,"median":-1.855896,"eighty":-0.911522,"marketCap":94703583},{"date":"2022-06-10","current":-2.642445,"twenty":-4.651125,"median":-1.855896,"eighty":-0.911522,"marketCap":100748493},{"date":"2022-06-17","current":-2.906689,"twenty":-4.651125,"median":-1.855896,"eighty":-0.911522,"marketCap":110823342},{"date":"2022-06-24","current":-2.994771,"twenty":-4.651125,"median":-1.854749,"eighty":-0.911004,"marketCap":114181625},{"date":"2022-07-01","current":-3.074044,"twenty":-4.651125,"median":-1.854749,"eighty":-0.911004,"marketCap":117204080},{"date":"2022-07-08","current":-2.792183,"twenty":-4.651125,"median":-1.854749,"eighty":-0.911004,"marketCap":106457574},{"date":"2022-07-15","current":-2.668869,"twenty":-4.651125,"median":-1.854749,"eighty":-0.911004,"marketCap":101755977},{"date":"2022-07-22","current":-2.71291,"twenty":-4.62997,"median":-1.854749,"eighty":-0.911004,"marketCap":103435119},{"date":"2022-07-29","current":-2.756951,"twenty":-4.60922,"median":-1.854749,"eighty":-0.911004,"marketCap":105114261},{"date":"2022-08-05","current":-2.845032,"twenty":-4.60922,"median":-1.854749,"eighty":-0.911004,"marketCap":108472544},{"date":"2022-08-12","current":-2.704102,"twenty":-4.60922,"median":-1.854749,"eighty":-0.911004,"marketCap":103099291},{"date":"2022-08-19","current":-2.501514,"twenty":-4.593273,"median":-1.854749,"eighty":-0.911004,"marketCap":95375240},{"date":"2022-08-26","current":-2.307735,"twenty":-4.524743,"median":-1.854749,"eighty":-0.911004,"marketCap":87987017},{"date":"2022-09-02","current":-2.087531,"twenty":-4.503428,"median":-1.854749,"eighty":-0.911004,"marketCap":79591309},{"date":"2022-09-09","current":-1.99945,"twenty":-4.410326,"median":-1.854749,"eighty":-0.911004,"marketCap":76233026},{"date":"2022-09-16","current":-2.562657,"twenty":-4.358255,"median":-1.854749,"eighty":-0.911004,"marketCap":105222706},{"date":"2022-09-23","current":-2.666677,"twenty":-4.348809,"median":-1.854749,"eighty":-0.911004,"marketCap":109493738},{"date":"2022-09-30","current":-2.591026,"twenty":-4.348809,"median":-1.854749,"eighty":-0.911004,"marketCap":106387533},{"date":"2022-10-07","current":-2.534288,"twenty":-4.348809,"median":-1.854749,"eighty":-0.911004,"marketCap":104057879},{"date":"2022-10-14","current":-2.089842,"twenty":-4.348809,"median":-1.854749,"eighty":-0.911004,"marketCap":85808923},{"date":"2022-10-21","current":-1.872347,"twenty":-4.348809,"median":-1.854749,"eighty":-0.911004,"marketCap":76878582},{"date":"2022-10-28","current":-1.493373,"twenty":-4.348809,"median":-1.825066,"eighty":-0.911004,"marketCap":61317899},{"date":"2022-11-04","current":-1.435073,"twenty":-4.348809,"median":-1.767312,"eighty":-0.911004,"marketCap":58924107},{"date":"2022-11-11","current":-1.342917,"twenty":-4.348809,"median":-1.748037,"eighty":-0.911004,"marketCap":57819280},{"date":"2022-11-18","current":-1.454114,"twenty":-4.348809,"median":-1.724156,"eighty":-0.911004,"marketCap":62606863},{"date":"2022-11-25","current":-1.334363,"twenty":-4.348809,"median":-1.712467,"eighty":-0.911004,"marketCap":57451004},{"date":"2022-12-02","current":-1.522543,"twenty":-4.348809,"median":-1.690179,"eighty":-0.911004,"marketCap":65553069},{"date":"2022-12-09","current":-1.274488,"twenty":-4.348809,"median":-1.676896,"eighty":-0.911004,"marketCap":54873074},{"date":"2022-12-16","current":-1.248827,"twenty":-4.348809,"median":-1.635337,"eighty":-0.911004,"marketCap":53768247},{"date":"2022-12-23","current":-1.779151,"twenty":-4.348809,"median":-1.631163,"eighty":-0.911004,"marketCap":76601339},{"date":"2022-12-30","current":-1.770597,"twenty":-4.348809,"median":-1.631163,"eighty":-0.911004,"marketCap":76233063},{"date":"2023-01-06","current":-1.531096,"twenty":-4.348809,"median":-1.629152,"eighty":-0.911004,"marketCap":65921344},{"date":"2023-01-13","current":-1.667954,"twenty":-4.348809,"median":-1.629152,"eighty":-0.911004,"marketCap":71813755},{"date":"2023-01-20","current":-1.710722,"twenty":-4.348809,"median":-1.629152,"eighty":-0.911004,"marketCap":73655134},{"date":"2023-01-27","current":-1.856219,"twenty":-4.348809,"median":-1.629152,"eighty":-0.911004,"marketCap":79919503},{"date":"2023-02-03","current":-2.300921,"twenty":-4.348809,"median":-1.629152,"eighty":-0.911004,"marketCap":99066155},{"date":"2023-02-10","current":-2.325881,"twenty":-4.348809,"median":-1.629152,"eighty":-0.911004,"marketCap":102380636},{"date":"2023-02-17","current":-2.192017,"twenty":-4.348809,"median":-1.631163,"eighty":-0.911004,"marketCap":96488225},{"date":"2023-02-24","current":-1.807159,"twenty":-4.348809,"median":-1.667954,"eighty":-0.911004,"marketCap":79547544},{"date":"2023-03-03","current":-2.09162,"twenty":-4.348809,"median":-1.687059,"eighty":-0.911004,"marketCap":92068917},{"date":"2023-03-10","current":-1.823892,"twenty":-4.348809,"median":-1.702168,"eighty":-0.911004,"marketCap":80284096},{"date":"2023-03-17","current":-1.522699,"twenty":-4.348809,"median":-1.702578,"eighty":-0.911004,"marketCap":67026171},{"date":"2023-03-24","current":-1.63983,"twenty":-4.348809,"median":-1.710722,"eighty":-0.911004,"marketCap":72182031},{"date":"2023-03-31","current":-1.606364,"twenty":-4.34692,"median":-1.708742,"eighty":-0.911522,"marketCap":70708928},{"date":"2023-04-06","current":-1.648196,"twenty":-4.34692,"median":-1.710722,"eighty":-0.911522,"marketCap":72550306},{"date":"2023-04-14","current":-1.564532,"twenty":-4.348809,"median":-1.710722,"eighty":-0.911004,"marketCap":68867550},{"date":"2023-04-21","current":-1.631463,"twenty":-4.350699,"median":-1.710722,"eighty":-0.910487,"marketCap":71813755},{"date":"2023-04-28","current":-1.731861,"twenty":-4.350699,"median":-1.713798,"eighty":-0.910487,"marketCap":76233063},{"date":"2023-05-05","current":-1.78206,"twenty":-4.350699,"median":-1.722271,"eighty":-0.910487,"marketCap":78442717},{"date":"2023-05-12","current":-1.698395,"twenty":-4.350699,"median":-1.725993,"eighty":-0.910487,"marketCap":74759961},{"date":"2023-05-19","current":-1.587592,"twenty":-4.352588,"median":-1.727829,"eighty":-0.909969,"marketCap":76969615},{"date":"2023-05-26","current":-1.602784,"twenty":-4.354477,"median":-1.729845,"eighty":-0.909452,"marketCap":77706166},{"date":"2023-06-02","current":-1.496438,"twenty":-4.354477,"median":-1.729845,"eighty":-0.909452,"marketCap":72550306},{"date":"2023-06-09","current":-1.504034,"twenty":-4.354477,"median":-1.729845,"eighty":-0.912039,"marketCap":72918582},{"date":"2023-06-16","current":-1.557207,"twenty":-4.358255,"median":-1.733003,"eighty":-0.915766,"marketCap":75496512},{"date":"2023-06-23","current":-1.633168,"twenty":-4.360144,"median":-1.740415,"eighty":-0.916684,"marketCap":79179269},{"date":"2023-06-30","current":-1.412881,"twenty":-4.362033,"median":-1.742413,"eighty":-0.918061,"marketCap":68499274},{"date":"2023-07-07","current":-1.534419,"twenty":-4.362033,"median":-1.742413,"eighty":-0.918061,"marketCap":74391685},{"date":"2023-07-14","current":-1.549611,"twenty":-4.362033,"median":-1.742413,"eighty":-0.918061,"marketCap":75128236},{"date":"2023-07-21","current":-1.504034,"twenty":-4.362033,"median":-1.742413,"eighty":-0.918061,"marketCap":72918582},{"date":"2023-07-28","current":-1.3749,"twenty":-4.362033,"median":-1.742413,"eighty":-0.918061,"marketCap":66657896},{"date":"2023-08-04","current":-1.359708,"twenty":-4.362033,"median":-1.742413,"eighty":-0.918061,"marketCap":65921344},{"date":"2023-08-11","current":-1.109035,"twenty":-4.362033,"median":-1.742413,"eighty":-0.918061,"marketCap":53768247},{"date":"2023-08-18","current":-1.131824,"twenty":-4.362033,"median":-1.742413,"eighty":-0.925314,"marketCap":54873074},{"date":"2023-08-25","current":-1.078651,"twenty":-4.362033,"median":-1.742413,"eighty":-0.935851,"marketCap":52295145},{"date":"2023-09-01","current":-1.093843,"twenty":-4.362033,"median":-1.742413,"eighty":-0.958371,"marketCap":53031696},{"date":"2023-09-08","current":-1.101439,"twenty":-4.362033,"median":-1.742413,"eighty":-0.965311,"marketCap":53399972},{"date":"2023-09-15","current":-1.10226,"twenty":-4.362033,"median":-1.742413,"eighty":-0.972902,"marketCap":57082728},{"date":"2023-09-22","current":-0.988478,"twenty":-4.362033,"median":-1.742413,"eighty":-0.977073,"marketCap":51190318},{"date":"2023-09-29","current":-0.956477,"twenty":-4.362033,"median":-1.742413,"eighty":-0.978189,"marketCap":49533077},{"date":"2023-10-06","current":-0.803583,"twenty":-4.362033,"median":-1.742413,"eighty":-0.978189,"marketCap":41615150},{"date":"2023-10-13","current":-0.631986,"twenty":-4.362033,"median":-1.742413,"eighty":-0.978189,"marketCap":32728658},{"date":"2023-10-19","current":-0.739581,"twenty":-4.362033,"median":-1.742413,"eighty":-0.978189,"marketCap":38300669},{"date":"2023-10-27","current":-0.696913,"twenty":-4.363922,"median":-1.745994,"eighty":-0.990005,"marketCap":36091015},{"date":"2023-11-03","current":-0.696913,"twenty":-4.363922,"median":-1.745994,"eighty":-0.990005,"marketCap":36091015},{"date":"2023-11-10","current":-0.604465,"twenty":-4.363922,"median":-1.745994,"eighty":-0.990005,"marketCap":31303431},{"date":"2023-11-17","current":-0.527179,"twenty":-4.363922,"median":-1.745994,"eighty":-0.990005,"marketCap":29775087},{"date":"2023-11-24","current":-0.540217,"twenty":-4.363922,"median":-1.745994,"eighty":-0.990005,"marketCap":30511458},{"date":"2023-12-01","current":-0.54162,"twenty":-4.363922,"median":-1.745994,"eighty":-0.990005,"marketCap":30590709},{"date":"2023-12-08","current":-0.645454,"twenty":-4.363922,"median":-1.744878,"eighty":-0.989394,"marketCap":36455249},{"date":"2023-12-15","current":-0.615918,"twenty":-4.363922,"median":-1.744878,"eighty":-0.989394,"marketCap":34787025},{"date":"2023-12-22","current":-0.630931,"twenty":-4.363922,"median":-1.744878,"eighty":-0.989394,"marketCap":35635006},{"date":"2023-12-29","current":-0.693723,"twenty":-4.363922,"median":-1.745994,"eighty":-0.990005,"marketCap":39181467},{"date":"2024-01-05","current":-0.686637,"twenty":-4.363922,"median":-1.74711,"eighty":-0.992653,"marketCap":38781252},{"date":"2024-01-12","current":-0.722628,"twenty":-4.363922,"median":-1.74711,"eighty":-0.992653,"marketCap":40814029},{"date":"2024-01-19","current":-0.701581,"twenty":-4.363922,"median":-1.747574,"eighty":-1.003243,"marketCap":39625271},{"date":"2024-01-26","current":-0.78577,"twenty":-4.363922,"median":-1.74711,"eighty":-0.992653,"marketCap":44380303},{"date":"2024-02-02","current":-0.694565,"twenty":-4.363922,"median":-1.74711,"eighty":-0.992653,"marketCap":39229018},{"date":"2024-02-09","current":-0.701581,"twenty":-4.363922,"median":-1.74711,"eighty":-0.992653,"marketCap":39625271},{"date":"2024-02-16","current":-0.84364,"twenty":-4.363922,"median":-1.74711,"eighty":-0.992653,"marketCap":47946577},{"date":"2024-02-23","current":-1.115557,"twenty":-4.363922,"median":-1.74711,"eighty":-1.010044,"marketCap":63400433},{"date":"2024-03-01","current":-1.150418,"twenty":-4.363922,"median":-1.745994,"eighty":-1.017828,"marketCap":65381697},{"date":"2024-03-08","current":-1.261974,"twenty":-4.363922,"median":-1.745994,"eighty":-1.030385,"marketCap":71721740},{"date":"2024-03-15","current":-1.268946,"twenty":-4.363922,"median":-1.745994,"eighty":-1.035669,"marketCap":72117993},{"date":"2024-03-22","current":-1.338668,"twenty":-4.363922,"median":-1.745994,"eighty":-1.044789,"marketCap":76080520},{"date":"2024-03-28","current":-1.561779,"twenty":-4.363922,"median":-1.745994,"eighty":-1.046927,"marketCap":88760607},{"date":"2024-04-05","current":-1.610585,"twenty":-4.363922,"median":-1.748037,"eighty":-1.05054,"marketCap":91534376},{"date":"2024-04-12","current":-1.81278,"twenty":-4.363922,"median":-1.749415,"eighty":-1.059625,"marketCap":103025704},{"date":"2024-04-19","current":-2.330006,"twenty":-4.363922,"median":-1.763974,"eighty":-1.064184,"marketCap":132421235},{"date":"2024-04-26","current":-1.835762,"twenty":-4.363922,"median":-1.769122,"eighty":-1.078767,"marketCap":104331882},{"date":"2024-05-03","current":-2.097005,"twenty":-4.363922,"median":-1.779151,"eighty":-1.086247,"marketCap":119179111},{"date":"2024-05-10","current":-2.012278,"twenty":-4.363922,"median":-1.802976,"eighty":-1.086247,"marketCap":114363793},{"date":"2024-05-17","current":-1.764731,"twenty":-4.363922,"median":-1.817352,"eighty":-1.090701,"marketCap":102726776},{"date":"2024-05-24","current":-2.109405,"twenty":-4.363922,"median":-1.825919,"eighty":-1.094447,"marketCap":122790599},{"date":"2024-05-31","current":-2.860795,"twenty":-4.363922,"median":-1.839504,"eighty":-1.101439,"marketCap":166529735},{"date":"2024-06-07","current":-3.854177,"twenty":-4.363922,"median":-1.856831,"eighty":-1.109035,"marketCap":224355471},{"date":"2024-06-14","current":-3.557775,"twenty":-4.363922,"median":-1.87032,"eighty":-1.116631,"marketCap":207101656},{"date":"2024-06-21","current":-2.599382,"twenty":-4.363922,"median":-1.880156,"eighty":-1.131824,"marketCap":151312644},{"date":"2024-06-28","current":-3.539843,"twenty":-4.367554,"median":-1.892247,"eighty":-1.151651,"marketCap":206057779},{"date":"2024-07-05","current":-3.809067,"twenty":-4.367554,"median":-1.907557,"eighty":-1.158958,"marketCap":221729612},{"date":"2024-07-12","current":-3.909546,"twenty":-4.367554,"median":-1.928985,"eighty":-1.16573,"marketCap":227578595},{"date":"2024-07-15","current":-4.293193,"twenty":-4.367554,"median":-1.930971,"eighty":-1.16573,"marketCap":249911074},{"date":"2024-08-02","current":-4.028294,"twenty":-4.427847,"median":-1.9429,"eighty":-1.165317,"marketCap":234491029},{"date":"2024-08-09","current":-4.041624,"twenty":-4.427847,"median":-1.976729,"eighty":-1.165317,"marketCap":235266956},{"date":"2024-08-16","current":-4.013095,"twenty":-4.427847,"median":-2.000368,"eighty":-1.165317,"marketCap":233606248},{"date":"2024-08-23","current":-4.041624,"twenty":-4.427847,"median":-2.010268,"eighty":-1.165317,"marketCap":235266956},{"date":"2024-08-30","current":-4.517109,"twenty":-4.48883,"median":-2.024024,"eighty":-1.165317,"marketCap":262945422},{"date":"2024-09-06","current":-4.15574,"twenty":-4.496574,"median":-2.037601,"eighty":-1.165317,"marketCap":241909788},{"date":"2024-09-13","current":-4.964065,"twenty":-4.561867,"median":-2.064111,"eighty":-1.16573,"marketCap":288963179},{"date":"2024-09-20","current":-4.583677,"twenty":-4.607004,"median":-2.083335,"eighty":-1.16573,"marketCap":266820407},{"date":"2024-09-27","current":-4.640735,"twenty":-4.643668,"median":-2.09398,"eighty":-1.16573,"marketCap":270141823},{"date":"2024-10-04","current":-4.659754,"twenty":-4.661985,"median":-2.10675,"eighty":-1.167074,"marketCap":271248961},{"date":"2024-10-11","current":-4.486838,"twenty":-4.671527,"median":-2.135288,"eighty":-1.17998,"marketCap":261183353},{"date":"2024-10-18","current":-4.554093,"twenty":-4.674327,"median":-2.180166,"eighty":-1.185651,"marketCap":265098307},{"date":"2024-10-25","current":-5.322716,"twenty":-4.700029,"median":-2.217881,"eighty":-1.185651,"marketCap":309840638},{"date":"2024-10-31","current":-5.226638,"twenty":-4.716929,"median":-2.260796,"eighty":-1.196691,"marketCap":304247846},{"date":"2024-11-08","current":-5.495657,"twenty":-4.729428,"median":-2.287642,"eighty":-1.217297,"marketCap":319907662},{"date":"2024-11-15","current":-4.51858,"twenty":-4.739636,"median":-2.308824,"eighty":-1.243404,"marketCap":313196312},{"date":"2024-11-22","current":-4.062778,"twenty":-4.739636,"median":-2.335706,"eighty":-1.253312,"marketCap":281603300},{"date":"2024-11-29","current":-4.213251,"twenty":-4.739636,"median":-2.36935,"eighty":-1.253312,"marketCap":292033052},{"date":"2024-12-06","current":-4.380443,"twenty":-4.739636,"median":-2.388307,"eighty":-1.253312,"marketCap":303621665},{"date":"2024-12-13","current":-3.878866,"twenty":-4.739636,"median":-2.409658,"eighty":-1.253312,"marketCap":268855826},{"date":"2024-12-20","current":-3.536121,"twenty":-4.739636,"median":-2.454886,"eighty":-1.254805,"marketCap":245099169},{"date":"2024-12-27","current":-4.188172,"twenty":-4.739636,"median":-2.48957,"eighty":-1.267734,"marketCap":290294760},{"date":"2025-01-03","current":-4.305207,"twenty":-4.739636,"median":-2.519131,"eighty":-1.274488,"marketCap":298406789},{"date":"2025-01-10","current":-4.355364,"twenty":-4.741538,"median":-2.562657,"eighty":-1.276855,"marketCap":301883373},{"date":"2025-01-17","current":-3.979181,"twenty":-4.741538,"median":-2.590311,"eighty":-1.295017,"marketCap":275808994},{"date":"2025-01-24","current":-4.171453,"twenty":-4.741538,"median":-2.595204,"eighty":-1.317256,"marketCap":289135899},{"date":"2025-01-31","current":-4.355364,"twenty":-4.741538,"median":-2.642445,"eighty":-1.32438,"marketCap":301883373},{"date":"2025-02-07","current":-4.263409,"twenty":-4.741538,"median":-2.649509,"eighty":-1.325158,"marketCap":295509636},{"date":"2025-02-14","current":-4.093336,"twenty":-4.741538,"median":-2.660874,"eighty":-1.335385,"marketCap":291175394},{"date":"2025-02-21","current":-3.940155,"twenty":-4.741538,"median":-2.668869,"eighty":-1.340368,"marketCap":280279017},{"date":"2025-02-28","current":-3.608263,"twenty":-4.741538,"median":-2.689309,"eighty":-1.354842,"marketCap":256670202},{"date":"2025-03-07","current":-3.293391,"twenty":-4.74344,"median":-2.710865,"eighty":-1.366925,"marketCap":234272094},{"date":"2025-03-14","current":-3.182761,"twenty":-4.74344,"median":-2.717012,"eighty":-1.3749,"marketCap":226402489},{"date":"2025-03-21","current":-2.629607,"twenty":-4.74344,"median":-2.721718,"eighty":-1.385685,"marketCap":187054463},{"date":"2025-03-28","current":-2.484936,"twenty":-4.74344,"median":-2.721718,"eighty":-1.40329,"marketCap":176763441},{"date":"2025-04-04","current":-2.331755,"twenty":-4.74344,"median":-2.721718,"eighty":-1.421996,"marketCap":165867064},{"date":"2025-04-11","current":-2.101984,"twenty":-4.741538,"median":-2.721718,"eighty":-1.442689,"marketCap":149522499},{"date":"2025-04-17","current":-2.246655,"twenty":-4.741538,"median":-2.721718,"eighty":-1.457447,"marketCap":159813522},{"date":"2025-04-25","current":-3.369982,"twenty":-4.74344,"median":-2.723491,"eighty":-1.471534,"marketCap":239720283},{"date":"2025-05-02","current":-3.369982,"twenty":-4.74344,"median":-2.735453,"eighty":-1.47285,"marketCap":239720283},{"date":"2025-05-09","current":-3.16574,"twenty":-4.74344,"median":-2.748143,"eighty":-1.489785,"marketCap":225191781},{"date":"2025-05-16","current":-2.952219,"twenty":-4.74344,"median":-2.766189,"eighty":-1.504034,"marketCap":215506113},{"date":"2025-05-23","current":-3.234173,"twenty":-4.74344,"median":-2.774567,"eighty":-1.519889,"marketCap":236088157},{"date":"2025-05-30","current":-3.445638,"twenty":-4.74344,"median":-2.783375,"eighty":-1.531096,"marketCap":251524690},{"date":"2025-06-06","current":-5.049293,"twenty":-4.775682,"median":-2.792183,"eighty":-1.538977,"marketCap":368588260},{"date":"2025-06-13","current":-5.15473,"twenty":-4.795313,"median":-2.803707,"eighty":-1.548161,"marketCap":376284999},{"date":"2025-06-20","current":-4.768125,"twenty":-4.80269,"median":-2.8098,"eighty":-1.547799,"marketCap":348063624},{"date":"2025-06-27","current":-5.049293,"twenty":-4.814987,"median":-2.819811,"eighty":-1.557207,"marketCap":368588260},{"date":"2025-07-03","current":-5.646773,"twenty":-4.838417,"median":-2.827538,"eighty":-1.561779,"marketCap":412203112},{"date":"2025-07-11","current":-6.15053,"twenty":-4.867546,"median":-2.840961,"eighty":-1.564532,"marketCap":448976419},{"date":"2025-07-18","current":-6.490274,"twenty":-4.883238,"median":-2.846554,"eighty":-1.564532,"marketCap":473777021},{"date":"2025-07-25","current":-6.981045,"twenty":-4.898596,"median":-2.846554,"eighty":-1.564532,"marketCap":509602294},{"date":"2025-08-01","current":-7.090963,"twenty":-4.913351,"median":-2.846554,"eighty":-1.564532,"marketCap":517626110},{"date":"2025-08-08","current":-6.638095,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":484567636},{"date":"2025-08-15","current":-7.69876,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":561994063},{"date":"2025-08-22","current":-8.294639,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":605492055},{"date":"2025-08-29","current":-8.604496,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":628111011},{"date":"2025-09-05","current":-8.795178,"twenty":-4.92196,"median":-2.846101,"eighty":-1.563981,"marketCap":642030369},{"date":"2025-09-12","current":-9.498315,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":693358000},{"date":"2025-09-19","current":-10.007166,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":744653217},{"date":"2025-09-26","current":-10.702786,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":796415697},{"date":"2025-10-03","current":-11.215348,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":834556471},{"date":"2025-10-10","current":-10.776009,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":801864379},{"date":"2025-10-17","current":-10.824824,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":805496834},{"date":"2025-10-24","current":-11.009905,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":819269029},{"date":"2025-10-31","current":-11.986393,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":891931470},{"date":"2025-11-07","current":-11.717859,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":871949299},{"date":"2025-11-14","current":-11.941745,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":921711668},{"date":"2025-11-21","current":-11.593344,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":894820683},{"date":"2025-11-28","current":-11.65942,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":899920698},{"date":"2025-12-05","current":-11.653413,"twenty":-4.928106,"median":-2.846554,"eighty":-1.564532,"marketCap":899457060},{"date":"2025-12-12","current":-1.681936,"twenty":-4.920424,"median":-2.845566,"eighty":-1.564532,"marketCap":129818544},{"date":"2025-12-19","current":-2.222558,"twenty":-4.892883,"median":-2.833827,"eighty":-1.564532,"marketCap":171545934},{"date":"2025-12-26","current":-3.291789,"twenty":-4.8762,"median":-2.83044,"eighty":-1.564532,"marketCap":254073437},{"date":"2026-01-02","current":-2.835263,"twenty":-4.867546,"median":-2.827538,"eighty":-1.564532,"marketCap":218836975},{"date":"2026-01-09","current":-2.847277,"twenty":-4.826702,"median":-2.821014,"eighty":-1.564532,"marketCap":219764250},{"date":"2026-01-16","current":-3.375886,"twenty":-4.80269,"median":-2.821014,"eighty":-1.564532,"marketCap":260564364},{"date":"2026-01-23","current":-3.928522,"twenty":-4.795313,"median":-2.821014,"eighty":-1.564532,"marketCap":303219029},{"date":"2026-01-30","current":-3.904494,"twenty":-4.771667,"median":-2.821014,"eighty":-1.564532,"marketCap":301364479},{"date":"2026-02-06","current":-3.508038,"twenty":-4.745342,"median":-2.821014,"eighty":-1.564532,"marketCap":270764393},{"date":"2026-02-13","current":-4.36102,"twenty":-4.72286,"median":-2.821014,"eighty":-1.564532,"marketCap":336600941},{"date":"2026-02-20","current":-4.04498,"twenty":-4.715776,"median":-2.821014,"eighty":-1.564532,"marketCap":340700563},{"date":"2026-02-27","current":-4.057312,"twenty":-4.680354,"median":-2.821014,"eighty":-1.564532,"marketCap":341739284},{"date":"2026-03-06","current":-3.859996,"twenty":-4.675631,"median":-2.821014,"eighty":-1.564532,"marketCap":325119744},{"date":"2026-03-13","current":-3.724341,"twenty":-4.670908,"median":-2.821014,"eighty":-1.564532,"marketCap":313693811},{"date":"2026-03-20","current":-3.046067,"twenty":-4.670908,"median":-2.821014,"eighty":-1.564532,"marketCap":256564143},{"date":"2026-03-27","current":-4.007983,"twenty":-4.670908,"median":-2.821014,"eighty":-1.564532,"marketCap":337584399},{"date":"2026-04-02","current":-3.859996,"twenty":-4.670908,"median":-2.821014,"eighty":-1.564532,"marketCap":325119744},{"date":"2026-04-10","current":-4.501273,"twenty":-4.670908,"median":-2.821014,"eighty":-1.564532,"marketCap":379133248},{"date":"2026-04-17","current":-4.365618,"twenty":-4.670908,"median":-2.83044,"eighty":-1.564532,"marketCap":367707315},{"date":"2026-04-24","current":-3.835332,"twenty":-4.670908,"median":-2.840961,"eighty":-1.564532,"marketCap":323042302},{"date":"2026-05-01","current":-3.946322,"twenty":-4.670908,"median":-2.846554,"eighty":-1.564532,"marketCap":332390793},{"date":"2026-05-08","current":-3.810667,"twenty":-4.670908,"median":-2.847143,"eighty":-1.564532,"marketCap":320964860},{"date":"2026-05-15","current":-4.358925,"twenty":-4.670908,"median":-2.852248,"eighty":-1.564532,"marketCap":355187014},{"date":"2026-05-22","current":-4.282003,"twenty":-4.670908,"median":-2.852248,"eighty":-1.564532,"marketCap":348919008},{"date":"2026-05-29","current":-4.19226,"twenty":-4.659759,"median":-2.852248,"eighty":-1.563981,"marketCap":341606334},{"date":"2026-06-05","current":-5.781986,"twenty":-4.656311,"median":-2.852248,"eighty":-1.564532,"marketCap":471145128},{"date":"2026-06-12","current":-4.948662,"twenty":-4.656311,"median":-2.852248,"eighty":-1.564532,"marketCap":403241728},{"date":"2026-06-18","current":-6.140956,"twenty":-4.656311,"median":-2.852248,"eighty":-1.564532,"marketCap":500395823},{"date":"2026-06-26","current":-6.448645,"twenty":-4.655581,"median":-2.852248,"eighty":-1.563981,"marketCap":525467848},{"date":"2026-07-02","current":-6.346082,"twenty":-4.655581,"median":-2.852248,"eighty":-1.563981,"marketCap":517110506},{"date":"2026-07-10","current":-6.576849,"twenty":-4.655581,"median":-2.852248,"eighty":-1.563981,"marketCap":535914524},{"date":"2026-07-17","current":-5.602501,"twenty":-4.655581,"median":-2.852248,"eighty":-1.563981,"marketCap":456519780},{"date":"2026-07-24","current":-6.807615,"twenty":-4.655581,"median":-2.852248,"eighty":-1.563981,"marketCap":554718543},{"date":"2026-07-31","current":-6.25634,"twenty":-4.657688,"median":-2.849762,"eighty":-1.563431,"marketCap":509797832},{"date":"2026-08-07","current":-6.025573,"twenty":-4.657688,"median":-2.849762,"eighty":-1.563431,"marketCap":490993814},{"date":"2026-08-14","current":-5.897369,"twenty":-4.657688,"median":-2.849762,"eighty":-1.563431,"marketCap":480547137},{"date":"2026-08-21","current":-5.974292,"twenty":-4.659764,"median":-2.849762,"eighty":-1.563431,"marketCap":486815143}],"updateTime":1787454450098},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RZLT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2632217645","title":"Rezolute reports Phase 3 sunRIZE CGM data showing improved hypoglycemia control with ersodetug","url":"https://stock-news.laohu8.com/highlight/detail?id=2632217645","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632217645?lang=en_us&edition=fundamental","pubTime":"2026-05-02 00:15","pubTimestamp":1777652129,"startTime":"0","endTime":"0","summary":"Rezolute reported expanded Phase 3 sunRIZE analyses for ersodetug in congenital hyperinsulinism, already presented at Pediatric Endocrine Society 2026 Annual Meeting.Additional continuous glucose monitoring readouts showed broadly consistent improvements in glycemic control for ersodetug versus placebo, despite missing statistical significance on a key secondary endpoint at Week 24.Open-label extension follow-up indicated sustained benefit, supporting reduction or discontinuation of background standard-of-care therapies in many patients.FDA Type B meeting on March 17, 2026 led agency to request submission of broader study dataset to inform next steps toward a potential approval path.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDLb8WTLK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","BK4585","IE00BN0W2W23.USD","BK4139","RZLT","BK4588","SG9999014021.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632645235","title":"Rezolute Announces Oral Presentation of Results From Its Phase 3 Sunrize Study of Ersodetug in Patients With Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2632645235","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632645235?lang=en_us&edition=fundamental","pubTime":"2026-05-02 00:15","pubTimestamp":1777652100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nTUA3LMZHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629333760","title":"Rezolute to present Phase 3 sunRIZE ersodetug data in congenital hyperinsulinism at PES meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629333760","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629333760?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:04","pubTimestamp":1776769444,"startTime":"0","endTime":"0","summary":"Rezolute scheduled an oral presentation of Phase 3 sunRIZE study results for ersodetug in congenital hyperinsulinism at Pediatric Endocrine Society Annual Meeting on May 1, 2026.Presentation will include previously announced topline results, indicating therapeutic benefit with evidence of target engagement.Update will also cover pre-specified analyses, offering additional support for drug activity in congenital hyperinsulinism.Post-hoc analyses are set to be disclosed, aimed at reinforcing overall clinical benefit narrative for ersodetug.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL75pGZh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","LU2095319765.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU2210149790.SGD","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BGHQF748.EUR","RZLT","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","SG9999014039.USD","LU2210150020.SGD","BK4112","SG9999014005.SGD","BK4585","NDAQ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624656813","title":"Rezolute publishes corporate presentation on ersodetug Phase 3 hyperinsulinism programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2624656813","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624656813?lang=en_us&edition=fundamental","pubTime":"2026-04-01 10:13","pubTimestamp":1775009581,"startTime":"0","endTime":"0","summary":"Rezolute highlighted ersodetug  as a late-stage antibody program targeting hypoglycemia across congenital hyperinsulinism and tumor-driven hyperinsulinism.Phase 3 sunRIZE study in congenital hyperinsulinism did not meet primary endpoint or key secondary glucose endpoints, with up to 45% reduction in hypoglycemia events in treated groups versus 40% on placebo.Safety profile showed no limiting findings, with early discontinuations tied to 2 serious hypersensitivity reactions.Pipeline timeline flagged 2H 2026 for tumor hyperinsulinism Phase 3 topline data.Liquidity update cited $133 million cash with runway to mid-2028.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rezolute Inc. published the original content used to generate this news b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL6knwQd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624558704","title":"Rezolute CFO Daron Evans reports purchase of common shares worth $28,500","url":"https://stock-news.laohu8.com/highlight/detail?id=2624558704","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624558704?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:02","pubTimestamp":1774990934,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rezolute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL4xgglB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Rezolute CFO Daron Evans reports purchase of common shares worth $28,500","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623734398","title":"Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT), Atara Biotherapeutics (ATRA) and Rezolute (RZLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623734398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623734398?lang=en_us&edition=fundamental","pubTime":"2026-03-30 21:10","pubTimestamp":1774876258,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sight Sciences (SGHT), Atara Biotherapeutics (ATRA) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sight-sciences-sght-atara-biotherapeutics-atra-and-rezolute-rzlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sight-sciences-sght-atara-biotherapeutics-atra-and-rezolute-rzlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4137","HCSG","LU0128526141.USD","SGHT","XBI","ATRA","BK4585","BK4539","XLV","BK4588","LU0029874061.USD","BK4139","LABU","BK4082","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622731970","title":"Rezolute Raised to Outperform From Neutral by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2622731970","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622731970?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:05","pubTimestamp":1774440300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RZLT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2026 08:05 ET (12:05 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622786350","title":"Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (SRPT), Rezolute (RZLT) and Demant (OtherWILLF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622786350","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622786350?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:31","pubTimestamp":1774438278,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sarepta Therapeutics (SRPT), Rezolute (RZLT) and Demant (WILLF). ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-sarepta-therapeutics-srpt-rezolute-rzlt-and-demant-otherwillf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-sarepta-therapeutics-srpt-rezolute-rzlt-and-demant-otherwillf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SRPT","RZLT","WILLF","BK4585","BK4082","BK4581","LU0128526141.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LABU","IE0002141913.USD","BK4139","BK4588","BK4137","XBI","IE00B2B36J28.USD","LU0029874061.USD","HCSG","XLV","SRPU","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622022090","title":"Rezolute upgraded to Outperform from Neutral at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2622022090","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622022090?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:37","pubTimestamp":1774435056,"startTime":"0","endTime":"0","summary":"Wedbush upgraded Rezolute (RZLT) to Outperform from Neutral with a price target of $5, up from $2. Published first on TheFly – the ultimate source ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rezolute-upgraded-to-outperform-from-neutral-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rezolute-upgraded-to-outperform-from-neutral-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622902276","title":"H.C. Wainwright Sticks to Their Buy Rating for Rezolute (RZLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622902276","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622902276?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:36","pubTimestamp":1774435005,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Rezolute today and set a price target of $5.00. According to TipRanks, Tsao is a 5-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-rezolute-rzlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-rezolute-rzlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622022280","title":"Wedbush Upgrades Rezolute to Outperform From Neutral, Raises Price Target to $5 From $2","url":"https://stock-news.laohu8.com/highlight/detail?id=2622022280","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622022280?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:35","pubTimestamp":1774434903,"startTime":"0","endTime":"0","summary":"Rezolute (RZLT) has an average rating of overweight and mean price target of $4.86, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622022585","title":"Analysts Are Bullish on Top Healthcare Stocks: NRX Pharmaceuticals (NRXP), Rezolute (RZLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622022585","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622022585?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:11","pubTimestamp":1774433472,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on NRX Pharmaceuticals (NRXP), Rezolute (RZLT) and Spec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-nrx-pharmaceuticals-nrxp-rezolute-rzlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-nrx-pharmaceuticals-nrxp-rezolute-rzlt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BLSX","BK4112","BK4139","BLSG","BK4581","RZLT","LU0128526141.USD","LU0029874061.USD","NRXP","BK4585","BK4007","BK4137","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621954010","title":"BUZZ-Rezolute rises after FDA talks on rare low blood sugar disease drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2621954010","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621954010?lang=en_us&edition=fundamental","pubTime":"2026-03-24 22:51","pubTimestamp":1774363892,"startTime":"0","endTime":"0","summary":"BUZZ-Rezolute rises after FDA talks on rare low blood sugar disease drug** Shares of biotech firm Rezolute RZLT.O rise 7% to $2.57** Co says it met the FDA to discuss next steps for its experimental drug ersodetug for congenital hyperinsulinism, a rare condition that causes dangerously low blood sugar in children** Says latestage trial showed the drug reduced low blood sugar episodes from baseline, but did not beat placebo on its main goal** Says trial results were affected by patient behavior, as families may have changed how closely blood sugar was monitored** Adds FDA acknowledged challenges of trials in this disease and said it will review full data before deciding on approval filing or additional studies** Early data from an ongoing extension study showed continued benefits - RZLT** RZLT fell ~52% in 2025","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nL4N40C1DJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621612500","title":"Rezolute Says It Had Encouraging FDA Meeting on Congenital Hyperinsulinism Drug Despite Missed Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2621612500","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621612500?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:53","pubTimestamp":1774353180,"startTime":"0","endTime":"0","summary":"Rezolute said the Food and Drug Administration encouraged it to submit study reports and analysis datasets for its ersodetug drug to treat congenital hyperinsulinism, despite its Phase 3 study missing its primary endpoint.In a meeting with the FDA, Rezolute presented information to support its belief that the primary endpoint was confounded as a result of behavioral factors.The company said the unblinded nature of self-monitored glucose, together with perceptions of treatment assignment, may have led to divergent behaviors between treatment groups during the study, which may have impacted the measurement of hypoglycemia.The company said the FDA acknowledged the challenges posed by those behavioral factors.The company said that after the FDA reviews study reports and analysis datasets it encouraged Rezolute to submit, it could determine whether there is enough evidence to support the submission of a marketing application or if additional information is required.The company expects to ha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","RZLT","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621662280","title":"Rezolute reports FDA meeting outcomes for its Phase 3 sunRIZE trial of ersodetug in congenital hyperinsulinism","url":"https://stock-news.laohu8.com/highlight/detail?id=2621662280","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621662280?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:02","pubTimestamp":1774350155,"startTime":"0","endTime":"0","summary":"Rezolute reported outcomes from an in-person FDA Type B meeting about sunRIZE, a Phase 3 multicenter, double-blind, randomized, placebo-controlled trial of ersodetug for congenital hyperinsulinism.SunRIZE previously showed reductions from baseline in hypoglycemia events, but did not meet its primary endpoint because reductions were not statistically significant versus placebo.CGM results showed consistent improvements versus placebo over the full pivotal treatment period, while nominal statistical significance was not achieved for time in hypoglycemia at Week 24.Rezolute plans to present pivotal sunRIZE outcomes at an upcoming scientific conference, and FDA encouraged submission of study reports and analysis datasets for independent review.The company said it expects to provide a program update in the second half of 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL42s7hy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","RZLT","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","LU2095319765.USD","BK4139","BK4585","NDAQ","LU2210150020.SGD","SG9999014021.USD","LU0314104364.USD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4588","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621906643","title":"Rezolute Provides Update on Its Congenital Hyperinsulinism Program Following FDA Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2621906643","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621906643?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:00","pubTimestamp":1774350000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUA3C4DWZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621066496","title":"Rezolute Inc - Expects Program Update in Second Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2621066496","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621066496?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:00","pubTimestamp":1774350000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUA3C4DWZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621066453","title":"Rezolute Inc: FDA Encouraged Company to Submit Study Reports and Analysis Datasets for Agency's Independent Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=2621066453","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621066453?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:00","pubTimestamp":1774350000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUA3C4DWZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621066285","title":"Rezolute Inc - FDA Acknowledges Challenges of Behavioral Factors and Smbg Limitations in Congenital Hi Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2621066285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621066285?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:00","pubTimestamp":1774350000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUA3C4DWZ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620623175","title":"XOMA Royalty FY 2025 revenue rose 83% to USD 52.15 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620623175","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620623175?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:01","pubTimestamp":1773828079,"startTime":"0","endTime":"0","summary":"XOMA Royalty published a press release reporting Q4 and full-year 2025 financial results. FY 2025 income and revenues rose 83% to USD 52.15 million, driven primarily by higher income related to VABYSMO and OJEMDA and milestone payments from Rezolute and Takeda. FY 2025 net income was USD 31.71 million, and net cash provided by operating activities was USD 2.87 million. For FY 2025, XOMA Royalty reported USD 50.5 million of cash receipts, including USD 33.6 million in royalties and commercial payments and USD 16.9 million in milestones, with total receipts up 9% and royalties up 68%. Owen Hughes said the company achieved positive operating cash flow in 2025 and highlighted 2026 catalysts including volixibat Phase 2b data in PSC in Q2 and ersodetug Phase 3 data in tumor HI in 2H.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL63mXy9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","IE00BGHQF748.EUR","NDAQ","LU2210149790.SGD","IE00BKPKM429.USD","BK4139","LU2095319765.USD","SG9999014021.USD","SG9999014039.USD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4112","SG9999014013.SGD","LU2210150020.SGD","RZLT","XOMA","BK4585","BK4588","LU0314104364.USD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":62,"code":"91000000","status":"200"}]}}